Weight Gain and Obesity in People with HIV

Todd T. Brown, MD, PhD
Professor of Medicine and Epidemiology
Division of Endocrinology, Diabetes, and Metabolism
Johns Hopkins University

Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc. Copyright © 2022. All rights reserved.

CME VIDEO

Top of page

How to Obtain CME Credit:

Top of page

Click here to take the CME Evaluation and Post-Meeting Survey

About the Presenters:

Top of page

Todd Brown is the primary endocrine consultant to the Johns Hopkins HIV Clinic. His research focuses on metabolic, endocrine, and skeletal abnormalities observed in HIV-infected patients. He is the co-chair of the Executive Committee of the MACS WIHS Combined Cohort Study and has served in leadership positions for the ACTG. He has mentored multiple trainees from across the country and around the world in the area of HIV Comorbidities and Aging. He has published widely on the topic of HIV and endocrine conditions and lectures internationally on this and other issues related to metabolic diseases in HIV.

Learning Objectives:

Top of page

At the completion of this educational session, learners will:
1. Become familiar with the current evidence regarding the impact of ART and specific ART medications on body weight.
2. Understand the impact of weight gain and adipose distribution on clinical outcomes.
3. Know the optimal approaches to weight gain prevention and treatment in PLWH.
4. Be aware of new treatments that are being developed for weight loss.

CME Information:

Top of page

This CME activity has approved for AMA PRA Category 1 Credit™ for May 18, 2022, as a live activity.  This activity will also be available as an enduring activity from May 19, 2022, through May 17, 2025.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

Accreditation Statement:

Top of page

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement:

Top of page

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Disclosure Statement:

Top of page

Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.

- Dr. James F. Braun (Course Director) has no relevant financial relationships to disclose.

- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.

- Dr. Todd T. Brown (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to ViiV, Gilead, Janssen, Merck, and Theratechnologies. Dr. Brown submitted their slides in advance for adequate peer review, and will support their presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.

Financial Support:

Top of page

This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare